Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Inventory Average (2021 - 2025)

Historic Inventory Average for Neuroone Medical Technologies (NMTC) over the last 5 years, with Q4 2025 value amounting to $1.9 million.

  • Neuroone Medical Technologies' Inventory Average fell 1474.07% to $1.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.9 million, marking a year-over-year decrease of 1474.07%. This contributed to the annual value of $2.4 million for FY2025, which is 1146.58% up from last year.
  • As of Q4 2025, Neuroone Medical Technologies' Inventory Average stood at $1.9 million, which was down 1474.07% from $2.1 million recorded in Q3 2025.
  • Neuroone Medical Technologies' 5-year Inventory Average high stood at $2.3 million for Q4 2024, and its period low was $75234.5 during Q3 2021.
  • In the last 5 years, Neuroone Medical Technologies' Inventory Average had a median value of $1.5 million in 2024 and averaged $1.3 million.
  • As far as peak fluctuations go, Neuroone Medical Technologies' Inventory Average soared by 67014.07% in 2022, and later tumbled by 1474.07% in 2025.
  • Quarter analysis of 5 years shows Neuroone Medical Technologies' Inventory Average stood at $163701.0 in 2021, then skyrocketed by 391.17% to $804046.0 in 2022, then skyrocketed by 107.41% to $1.7 million in 2023, then surged by 36.9% to $2.3 million in 2024, then decreased by 14.74% to $1.9 million in 2025.
  • Its Inventory Average stands at $1.9 million for Q4 2025, versus $2.1 million for Q3 2025 and $1.9 million for Q2 2025.